ATP [ Sodium adenosine triphosphate ]
Solution for intravenous administration 1% 1 ml x10 ampoules
- Complex therapy of muscular dystrophy and atrophy
- for arresting paroxysms of supraventricular tachycardia
- with spasms of peripheral vessels (intermittent claudication, Raynaud's disease, thromboangiitis obliterans)
- With central, peripheral and mixed forms of hereditary retinal pigment degeneration
ATP contraindications :
Individual hypersensitivity to the drug, acute myocardial infarction, arterial hypotension, severe forms of bradyarrhythmia, AV-II-III degree blockade, decompensated stage of heart failure, cardiogenic shock and other types of shock, QT prolongation syndrome, hemorrhagic stroke; inflammatory lung diseases, chronic obstructive pulmonary diseases (for example, bronchial asthma); pregnancy, lactation, child age. It can not be administered simultaneously with cardiac glycosides in large doses.